Table 3.
Comparison of the 4 commonest categories of lesions in adults regarding age, duration of symptoms, gender, bilaterality, and outcome
| Characteristic | Total (n = 83) n (%) | Fibro-degenerative / Proliferative (n = 56) n (%) | Melanocytic lesions (n = 9) n (%) | Inflammatory (n = 10) n (%) | Epithelial lesions (n = 8) n (%) |
|---|---|---|---|---|---|
| Age at presentation (years) Mean ± SD [Range] | 54.4 ± 17.7 [18.0–84.0] | 56.0 ± 16.3 [20.0–84.0] | 36.7 ± 17.3 [18.0–72.0] | 58.6 ± 17.8 [24.0–78.0] | 57.8 ± 18.6 [33.0–83.0] p = 0.013* |
| Duration of symptoms (months) Median (IQR) | 2.1 (0.2–11.0) | 3.9 (0.3–15.2) | 0.5 (0.1–11.0) | 0.5 (0.1–3.6) | 1.2 (0.1–4.4) p = 0.086 |
| Gender | |||||
| Male | 54 (65.1) | 40 (71.4) | 3 (33.3) | 5 (50.0) | 6 (75.0) p = 0.097 |
| Female | 29 (34.9) | 16 (28.6) | 6 (66.7) | 5 (50.0) | 2 (25.0) |
| Bilaterality | |||||
| Yes | 15 (18.1) | 11 (19.6) | 0 (0.0) | 4 (40.0) | 0 (0.0) p = 0.069 |
| No | 68 (81.9) | 45 (80.4) | 9 (100) | 6 (60.0) | 8 (100) |
| Duration of Follow-up (months) Median (IQR) | 3.6 (0.8–15.1) | 3.4 (0.9–17.8) | 0.7 (0.3–8.8) | 5.3 (1.6–17.1) | 6.9 (1.1–22.7) |
| Outcome | |||||
| Favorable | 66 (79.5) | 45 (80.4) | 7 (77.8) | 9 (90.0) | 5 (62.5) p = 0.333 |
| Unfavorable | 8 (9.6) | 6 (10.7) | 0 (0.0) | 1 (10.0) | 1 (12.5) |
| No FU | 9 (10.8) | 5 (8.9) | 2 (22.2) | (0.0) | 2 (25.0) |
*Statistically significant at 5% level of significance